Welch Innovation, LLC

Welch Innovation, LLCWelch Innovation, LLCWelch Innovation, LLC

Welch Innovation, LLC

Welch Innovation, LLCWelch Innovation, LLCWelch Innovation, LLC

Welch Innovation consulting, strategy, expert witness, new technologies

Welch Innovation consulting, strategy, expert witness, new technologiesWelch Innovation consulting, strategy, expert witness, new technologiesWelch Innovation consulting, strategy, expert witness, new technologies

christopher@welchinnovation.com

Welch Innovation consulting, strategy, expert witness, new technologies

Welch Innovation consulting, strategy, expert witness, new technologiesWelch Innovation consulting, strategy, expert witness, new technologiesWelch Innovation consulting, strategy, expert witness, new technologies

christopher@welchinnovation.com

About Us

Picture shows Chris Welch in a suit jacket and button-down.

Christopher J. Welch, Ph.D.

Scientific Consultanting in:

- Separation Science, Chirality and Stereochemistry

- Pharmaceutical Process R&D

- High Throughput Experimentation

- Pharmaceutical & Biopharmaceutical Industry

- New Research Technologies

- Strategic Planning

- Scientific Publication and Communication Strategy

Image shows one set on hands with a pencil and paper and one set of hands near laptop.

Biographical Sketch

  • Christopher J. Welch is a Principal with the consulting firm, Welch Innovation, LLC, the Executive Director of the Indiana Consortium for Analytical Science and Engineering (ICASE), Center Director of the NSF Center for Bioanalytic Metrology (CBM), Professor of Practice at the Berthiaume Institute for Precision Medicine, University of Notre Dame and President of Pacifichem, Inc., and serves  on the Scientific Advisory Boards of several small chemical businesses.  
  •  Dr. Welch has worked in a variety of chemistry-related fields including discovery synthesis of agrochemicals (Velsicol-Sandoz), development of reagents for improved immunodiagnostic assays (Abbott Laboratories), development and commercialization of chromatographic stationary phases, reagents and enantioselective catalysts within a small chemical business (Regis Technologies) invention and application of new purification, analysis and high throughput experimentation technologies for pharmaceutical process research (Merck & Co.) and as a  Science Advisor for the US FDA.  While at Merck, Dr. Welch created and administered Merck's postdoctoral research fellows program and managed a multi-million-dollar fund and research network that identified and evaluated new enabling technologies for pharmaceutical discovery and development.  Dr. Welch has authored more than 325 scientific publications and patents, is co-founder of the journal, Enantiomer, and a member of the editorial advisory board for Chirality and ACS Central Science.   Chris is a Fellow of the American Chemical Society (ACS) and the American Association for the Advancement of Science (AAAS) and the recipient of a number of awards, including the 2013 Chirality Medal (2015).  

Recent Publications

For a complete listing, see the GoogleScholar page here.

Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Copyright © 2026 Welch Innovation, LLC - All Rights Reserved.


Powered by